Docusign (NASDAQ:DOCU) CEO Allan Thygesen Sells 26,250 Shares of Stock

by · The Cerbat Gem

Docusign Inc. (NASDAQ:DOCUGet Free Report) CEO Allan Thygesen sold 26,250 shares of the firm’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $46.02, for a total transaction of $1,208,025.00. Following the completion of the transaction, the chief executive officer directly owned 159,038 shares in the company, valued at approximately $7,318,928.76. The trade was a 14.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Docusign Stock Performance

DOCU traded up $1.60 during trading on Wednesday, reaching $46.02. 3,492,477 shares of the company’s stock were exchanged, compared to its average volume of 4,953,224. The company’s fifty day moving average price is $46.93 and its 200-day moving average price is $51.11. The firm has a market capitalization of $8.79 billion, a PE ratio of 29.88, a P/E/G ratio of 1.31 and a beta of 0.90. Docusign Inc. has a fifty-two week low of $40.16 and a fifty-two week high of $86.65.

Docusign (NASDAQ:DOCUGet Free Report) last posted its quarterly earnings results on Thursday, June 4th. The company reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.99 by $0.10. Docusign had a return on equity of 17.48% and a net margin of 9.59%.The business had revenue of $830.24 million for the quarter, compared to analyst estimates of $824.71 million. During the same period last year, the company earned $0.90 EPS. The firm’s revenue was up 8.7% on a year-over-year basis. Research analysts forecast that Docusign Inc. will post 2.03 earnings per share for the current fiscal year.

Docusign declared that its Board of Directors has initiated a share buyback program on Tuesday, March 17th that authorizes the company to buyback $2.00 billion in outstanding shares. This buyback authorization authorizes the company to buy up to 21% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its shares are undervalued.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Central Pacific Bank Trust Division acquired a new position in Docusign during the 4th quarter worth approximately $25,000. Modus Advisors LLC bought a new stake in Docusign during the 4th quarter worth about $27,000. Torren Management LLC acquired a new position in shares of Docusign during the 4th quarter worth about $28,000. Aventura Private Wealth LLC bought a new position in shares of Docusign in the 4th quarter valued at about $30,000. Finally, True Wealth Design LLC grew its holdings in shares of Docusign by 105.2% in the 4th quarter. True Wealth Design LLC now owns 433 shares of the company’s stock valued at $30,000 after acquiring an additional 222 shares in the last quarter. 77.64% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

DOCU has been the topic of a number of analyst reports. Wells Fargo & Company cut their price target on shares of Docusign from $60.00 to $55.00 and set an “equal weight” rating on the stock in a research report on Friday, June 5th. Wedbush lowered their price objective on shares of Docusign from $60.00 to $58.00 and set a “neutral” rating for the company in a research report on Friday, June 5th. BTIG Research reduced their target price on Docusign from $70.00 to $60.00 and set a “buy” rating on the stock in a report on Friday, June 5th. Citigroup boosted their target price on Docusign from $50.00 to $54.00 and gave the company a “neutral” rating in a research note on Friday, June 5th. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of Docusign in a research report on Friday, June 5th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat, Docusign has a consensus rating of “Hold” and an average price target of $60.27.

Get Our Latest Stock Analysis on DOCU

More Docusign News

Here are the key news stories impacting Docusign this week:

  • Positive Sentiment: Zacks Research raised its FY2027 EPS estimate for Docusign to $1.69 from $1.53, suggesting stronger expected profitability over the next couple of years.
  • Positive Sentiment: The firm also increased its FY2028 EPS estimate to $1.76 from $1.89, and lifted Q1 2028 EPS to $0.47 from $0.45, reinforcing a more favorable near-to-midterm earnings view.
  • Positive Sentiment: Analysts boosted Q4 2028 EPS to $0.62 from $0.59 and Q1 2029 EPS to $0.73 from $0.51, indicating continued expectation for earnings growth further out. Docusign estimate revisions
  • Neutral Sentiment: Not all revisions were positive: Zacks trimmed Q2 2028 EPS to $0.28 from $0.43, Q3 2028 EPS to $0.38 from $0.41, and FY2029 EPS to $1.35 from $2.10, showing a mixed long-range outlook.
  • Neutral Sentiment: The current-year consensus estimate remains around $1.97 per share, so the latest changes mainly affect longer-dated forecasts rather than near-term results.

About Docusign

(Get Free Report)

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.

Featured Articles